By Joseph R. Pisegna (eds.)
This booklet presents the reader with a multidisciplinary method that's cutting-edge and displays enter from the ecu Neuroendocrine Tumor Society and the North American Neuroendocrine Tumor Society. specifically, the textual content makes a speciality of the pathophysiology of neuroendocrine tumors and contains a complete evaluation of the newest advancements in realizing the complicated hormone and receptor signaling that's vital for the long run improvement of effective pharmacological remedies. the quantity stories the pathological grading and staging structures delivering beneficial scientific details for the treating clinician in addition to an invaluable reference for pathologists. The scientific administration of neuroendocrine tumors is reviewed allowing the treating general practitioner to appreciate the diagnostic ways to differentiating a few of the sorts of neuroendocrine tumors. moreover, the remedies are reviewed in nice element and comprise novel radiological, surgical, and chemotherapeutic ways.
The reader will make the most of this publication as either a complete and fast reference advisor by using diagnostic and remedy algorithms. Written by way of overseas specialists of their specific box of research, Management of Pancreatic Neuroendocrine Tumors can be of significant worth to clinical oncologists, endocrinologists, gastroenterologists, pathologists, surgeons, and diagnostic and interventional radiologists.
Read or Download Management of Pancreatic Neuroendocrine Tumors PDF
Similar digestive organs books
Medical and radiologic examinations can't reliably distinguish benign or inflammatory pancreatic illness from carcinoma. The elevated use of pancreatic superb needle aspiration (FNA) in addition to advances in imaging ideas and the advent of endoscopic ultrasound tips have resulted in a lot better detection and popularity of pancreatic plenty.
A necessary source for gastroenterologists, hepatologists, liver surgeons, hepatobiliary surgeons, oncologists, and all these operating within the box of hepatocellular carcinoma (HCC), Hepatocellular Carcinoma: a pragmatic process covers the updates and up to date advancements at the prognosis, screening, and finished scientific and surgical administration of HCC.
Inflammatory Bowel sickness (IBD) is a protracted debilitating illness that happens at any age and in populations worldwide. Its pathogenesis is thought to contain a mixture of genetic susceptibility, immune and exterior environmental components, together with the intestine microbiota. altering elements resembling nutrition and the human intestine microbiota might therefore be a achievable replacement to suppressing the innate and adaptive immune responses.
"Highly powerful as a minimally invasive diagnostic and screening instrument, CT colonography (CTC) is a vital a part of modern medical armamentarium. during this concise, step by step guidebook, written by means of experts who additionally run education classes in CT colonography, readers will discover a wealth of knowledge for daily perform.
Extra resources for Management of Pancreatic Neuroendocrine Tumors
Ann Intern Med. 1998;129(6):484–94. Epub 1998/09/12. 15. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276(5311):404–7. Epub 1997/04/18. 16. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997;6(7):1169–75. Epub 1997/07/01.
Endocr Relat Cancer. 2003;10:459–62. 4. Caplin ME. Zollinger-Ellison syndrome. In: Modlin I, editor. From Gastrin to GERD a century of acid suppression. Hannover: Felsenstein; 2006. 5. Jensen RT. Gastrinomas: advances in diagnosis and management. Neuroendocrinology. 2004;80 Suppl 1:23–7. 6. Vanderveen K, Grant C. Insulinoma. Cancer Treat Res. 2010;153:235–52. 7. Arnold R, Wilke A, Rinke A, et al. Plasma chromogranin a as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors.
Epub 2007/09/12. 5. Frilling A, Sotiropoulos GC, Li J, Kornasiewicz O, Plockinger U. Multimodal management of neuroendocrine liver metastases. HPB (Oxford). 2010;12(6):361–79. Epub 2010/07/29. 6. Khasraw M, Gill A, Harrington T, Pavlakis N, Modlin I. Management of advanced neuroendocrine tumors with hepatic metastasis. J Clin Gastroenterol. 2009;43(9):838–47. Epub 2009/08/06. 7. Meeker A, Heaphy C. Gastroenteropancreatic endocrine tumors. Mol Cell Endocrinol. 2014;386(1–2):101–20. Epub 2013/08/03.